UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue
Total revenue	$ 3,298,000	$ 164,000
Costs and expenses
Cost of goods sold	35,585,000	100,000
Research and development expenses	4,963,000	5,053,000
Selling, general and administrative expenses	14,279,000	8,802,000
Loss on pre-existing agreement	0	7,852,000
Grant expense, net	173,000	8,000
Total costs and expenses	55,000,000	21,815,000
Operating loss	(51,702,000)	(21,651,000)
Other income (expense)
Interest expense, net	(338,000)	(21,000)
Interest expense - related party	(2,174,000)	0
Change in fair value, embedded derivative - related party	7,695,000	0
Change in fair value, warrants liability - related party	567,000	(224,000)
Income from equity in unconsolidated joint venture	0	440,000
Other income	119,000	0
Loss before income taxes	(45,833,000)	(21,456,000)
Income tax benefit	42,000	0
Net loss	$ (45,791,000)	$ (21,456,000)
Basic and diluted loss per share attributable to common shareholders
Basic (in dollars per share)	$ (0.85)	$ (0.42)
Diluted (in dollars per share)	$ (0.85)	$ (0.42)
Weighted average shares of common stock
Basic (in shares)	53,961,553	51,126,863
Diluted (in shares)	53,961,553	51,126,863